Health Care & Life Sciences » Medical Equipment & Supplies | Integra LifeSciences Holdings Corp.

Integra LifeSciences Holdings Corp. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
836
928
883
992
1,188
1,472
Cost of Goods Sold (COGS) incl. D&A
329
347
319
344
427
558
Gross Income
507
581
564
648
761
914
SG&A Expense
415
455
427
488
583
679
EBIT
-
126
-
161
177
235
Unusual Expense
98
68
63
53
132
125
Non Operating Income/Expense
2
3
1
1
1
12
Interest Expense
18
13
15
18
35
68
Pretax Income
25
43
61
90
11
57
Income Tax
8
9
54
16
53
3
Consolidated Net Income
17
34
7
75
65
61
Net Income
17
34
7
75
65
61
Net Income After Extraordinaries
17
34
17
75
65
61
Net Income Available to Common
17
34
4
75
65
61
EPS (Basic)
0.30
0.52
0.05
0.94
0.82
0.72
Basic Shares Outstanding
57
65
69
74
77
83
EPS (Diluted)
0.30
0.52
0.05
0.94
0.82
0.72
Diluted Shares Outstanding
57
66
71
79
79
84
EBITDA
139
187
198
233
266
351
Other Operating Expense
-
-
3
-
-
-
Non-Operating Interest Income
-
-
-
-
-
3

About Integra LifeSciences Holdings

View Profile
Address
311 Enterprise Drive
Plainsboro New Jersey 08536
United States
Employees -
Website http://www.integralife.com
Updated 07/08/2019
Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment includes neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices.